| Product Code: ETC6176317 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Cachexia Treatment Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Cachexia Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Cachexia Treatment Market - Industry Life Cycle |
3.4 Australia Cachexia Treatment Market - Porter's Five Forces |
3.5 Australia Cachexia Treatment Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 Australia Cachexia Treatment Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Australia Cachexia Treatment Market Revenues & Volume Share, By Dosage form, 2021 & 2031F |
3.8 Australia Cachexia Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Australia Cachexia Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Australia Cachexia Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Cachexia Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Australia leading to a higher incidence of cachexia |
4.2.2 Growing geriatric population in Australia who are more susceptible to cachexia |
4.2.3 Advancements in healthcare technology and research leading to better understanding and treatment options for cachexia |
4.3 Market Restraints |
4.3.1 High cost associated with cachexia treatment options may limit adoption |
4.3.2 Lack of awareness among healthcare professionals about cachexia leading to underdiagnosis and undertreatment |
4.3.3 Stringent regulatory requirements for approval of cachexia treatment drugs may slow down market growth |
5 Australia Cachexia Treatment Market Trends |
6 Australia Cachexia Treatment Market, By Types |
6.1 Australia Cachexia Treatment Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Australia Cachexia Treatment Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Australia Cachexia Treatment Market Revenues & Volume, By Dronabinol, 2021- 2031F |
6.1.4 Australia Cachexia Treatment Market Revenues & Volume, By Mega Sterol Acetate, 2021- 2031F |
6.1.5 Australia Cachexia Treatment Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.2 Australia Cachexia Treatment Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Australia Cachexia Treatment Market Revenues & Volume, By Cancer, 2021- 2031F |
6.2.3 Australia Cachexia Treatment Market Revenues & Volume, By Congestive Heart Failure (CHF), 2021- 2031F |
6.2.4 Australia Cachexia Treatment Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.2.5 Australia Cachexia Treatment Market Revenues & Volume, By Chronic Kidney Disease, 2021- 2031F |
6.2.6 Australia Cachexia Treatment Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.2.7 Australia Cachexia Treatment Market Revenues & Volume, By Chronic Obstructive Pulmonary disease (COPD), 2021- 2031F |
6.3 Australia Cachexia Treatment Market, By Dosage form |
6.3.1 Overview and Analysis |
6.3.2 Australia Cachexia Treatment Market Revenues & Volume, By Tablets, 2021- 2031F |
6.3.3 Australia Cachexia Treatment Market Revenues & Volume, By Injections, 2021- 2031F |
6.3.4 Australia Cachexia Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Cachexia Treatment Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Australia Cachexia Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Australia Cachexia Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.5 Australia Cachexia Treatment Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Australia Cachexia Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Australia Cachexia Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Australia Cachexia Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 Australia Cachexia Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Australia Cachexia Treatment Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Australia Cachexia Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Australia Cachexia Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Australia Cachexia Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 Australia Cachexia Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Cachexia Treatment Market Import-Export Trade Statistics |
7.1 Australia Cachexia Treatment Market Export to Major Countries |
7.2 Australia Cachexia Treatment Market Imports from Major Countries |
8 Australia Cachexia Treatment Market Key Performance Indicators |
8.1 Average time to diagnosis of cachexia in Australia |
8.2 Adoption rate of new cachexia treatment options by healthcare providers |
8.3 Patient satisfaction and quality of life improvement after receiving cachexia treatment |
8.4 Number of clinical trials and research studies focused on cachexia treatment in Australia |
8.5 Percentage of healthcare professionals trained in diagnosing and treating cachexia |
9 Australia Cachexia Treatment Market - Opportunity Assessment |
9.1 Australia Cachexia Treatment Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 Australia Cachexia Treatment Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Australia Cachexia Treatment Market Opportunity Assessment, By Dosage form, 2021 & 2031F |
9.4 Australia Cachexia Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Australia Cachexia Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Australia Cachexia Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Cachexia Treatment Market - Competitive Landscape |
10.1 Australia Cachexia Treatment Market Revenue Share, By Companies, 2024 |
10.2 Australia Cachexia Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here